6 BRAUNER et al. JANUARY 2003 Ð VOL. 23 , NO. 1 PDI rived mainly from macrophages but also from leukocytes and mesothelial cells (2) . Due to dilution of the minute volume of peritoneal liquid with 2 -3 L dialysis fluid, the fluid-phase leukocytes within the peritoneum in CAPDpatients ha ve a 100-to 1000-fold reduction in concentration compared to normal controls, and opsonin, IgG, C3, and fibronectin levels are also markedly reduced (3) . In addition, the ability to bind products of complement (C5a) and the phagocytic capacity of blood polymorphonuclear leukocytes from CAPD patients are reduced (4, 5) . Blood monocytes are the precursors of tissue macrophages and, after a period in the peripheral circulation, blood monocytes migrate into various tissues, differentiating and assuming tissue-specific properties. In spite of loss during peritoneal exchanges, peritoneal macrophages are the predominant cells in dialysate and act as the first line of cellular defense against bacterial invasion (6) . Daintain/allograft inflammatory factor-1 (AIF-1) is a novel Ca 2+ -binding peptide, originally demonstrated during chronic rejection of cardiac allograft in rats and humans (7, 8) . Also, after cerebral infarction, a prolonged upregulation of the peptide has been noted (9) , paralleling the findings seen in an inflammatory model of experimental autoimmune encephalitis. Likewise, experimental autoimmune neuritis (10) (11) (12) and uveitis (10, 11) induced daintain/AIF-1, and treatment with dexamethasone appeared to reduce the severity of the neurological disease, with only occasional AIF-1-positive monocytes found (11) . Recently, AIF-1 was shown to increase significantly in the infiltrate from biopsies of clinically rejected kidney transplants (13) .
In CAPD, as well as in transplantation, the introduction of a permanent foreign device or tissue may interact with the immune system. Furthermore, peritoneal macrophages exposed to dialysis effluent have been proposed to be in a chronic state of inflammation (14) . Therefore, we studied the occurrence of daintain/ AIF-1 in peritoneal dialysate at commencement and during a follow-up period, as well as the response of this peptide during peritonitis in CAPD patients. In addition, we investigated the production of daintain/ AIF-1 in monocyte and macrophage cell lines in response to bacterial stimulation and under exposure to interleukin (IL)-1β and interferon gamma (IFNγ).
SUBJECTS AND METHODS

PATIENTS WITH PERITONITIS
Fourteenpatients (10 men, 4 women; mean age 59years , range 44-77years) on C APD treatment at the Karolinska Hospital were enrolled in the study after giving their informed consent. The study was approved by the local Ethics Committee of the Karolinska Hospital. The patients were treated with the standard double-bag system (Baxter Healthcare, Deerfield, Illinois, USA; or Fresenius AG, Bad Homburg, Germany). One patient had two peritonitis episodes during the study period. A sample of dialysate from the night bag was collected from each patient during the noninfected state. When peritonitis was suspected, the patient brought the first cloudy dialysate bag to the ward for examination. Immediately after arrival, the effluent was drained, followed by two quick changes with dwell times of half an hour. Samples were obtained from these three bags and from night bags on days3 and10. All dialysate samples were saved at -70°C until analyzed. Bacterial cultures were performed on days1 and3. The patients served as their own controls since samples were obtained from them during the noninfected steady state. Serum samples were obtained from 8of the patients with peritonitis before the infection, on the first day of infection, and after about 3and 10da ys.
FOLLOW-UP STUDY
Five patients that just started their CAPD treatment were studied. Peritoneal effluents were obtained on the day of commencement of CAPD and at 1, 2, 4, and 8weeks .
BACTERIOLOGICAL CULTURES
Dialysate (100mL) w as filtered through a 0.45-µ pore size filter (Millipore, Bedford Massachusetts, USA), cultured on aerobic and anaerobic blood agar plates, and incubated for 4da ys at 37°C. All dialysates were processed within 2hours; 5mL of the dialysate was inoculated into aerobic and anaerobic blood culture bottles (BacT/Alert, Organon Teknika, Durham, North Carolina, USA) and incubated for 7da ys. Peritoneal cells were obtained from 3 CAPD patients that had never had peritonitis. Cells were seeded into 24-well flat bottom tissue culture plates (Nunc) at a concentration of 10 6 cells in 1mL complete culture media.
BACTERIAL STRAIN
Escherichiacoli DS17 expressing P-, S-, and type1 fimbriae and hemolysin, was obtained from a patient with acute pyelonephritis. Staphylococcus aureus strain Newman and S. epidermidis strain19 isolated from a patient with CAPD peritonitis were kindly provided by Professor J.-I. Flock, Huddinge, Sweden.
PREPARATION OF LIVE BACTERIAL ANTIGEN
The bacteria were grown overnight in Luria broth at 37°C. Bacteria were washed twice and the centrifuged cell pellet was resuspended in phosphate-buffered saline (PBS), to give a final bacterial concentration of 10 7 colony-forming units/mL, as measured by spectrophotometer. Accuracy was confirmed by viable count after each experiment.
PREPARATION OF HEAT-INACTIVATED BACTERIAL ANTIGEN
Heat inactivation of bacteria was performed after overnight culture at 37°C on colony factor antigen agar (E.coli ) or blood agar (S.aureus and S.epidermidis). The bacteria were then suspended in PBS and washed three times by repeated cycles of centrifugation at 3500rpm for 15minutes . The bacterial suspension was heat inactivated for 60minutes at 70°C. Finally, the bacteria were resuspended in culture medium to a final concentration of 10 8 bacteria/mL.
RECOMBINANT CYTOKINES
Recombinant human IL-1β was kindly provided by Professor T. Bartfai, Scripps, La Jolla, California, USA; recombinant human IFNγ was obtained from R&D Systems (Abingdon, UK), and recombinant human AIF-1 was kindly provided by Professor H.J. Schluesener, Tübingen, Germany.
BACTERIAL AND CYTOKINE STIMULATION OF CELLS
THP-1 monocytes and macrophages were seeded at a concentration of 10 6 cells in 1 mL of the complete culture media in 24-well flat-bottom tissue culture plates (Nunc). Each experiment was prepared in duplicate and cells were stimulated with either live or heat-inactivated bacteria alone or in combination with IFNγ. Cells were also stimulated with IFNγ or IL-1β alone. Live E. coli, S.aureus , and S.epidermidis were added in duplicate at a concentration of 10 7 bacteria/ mL (3 separate experiments each), while the same heatinactivated bacteria were added in duplicate at a concentration of 10 8 bacteria/mL (6 separate experiments each). Interleukin-1β was added in concentrations of 5, 10, or 20 ng/mL, and IFNγ in concentrations of 100 or 500U/mL. Cells incubated with culture medium alone were used as negative control. Aliquots of the supernatants from stimulated and negative controls were taken at 0, 2, 4, 6, 24, and 48 hours. Six experiments were performed on human peritoneal cells stimulated with live S.epidermidis for 6hours . Aliquots of the supernatants from stimulated and negative controls were taken at 0and 6hours . Supernatants were stored at -70°C until assays were performed.
CYTOKINE DETERMINATION
Interleukin-8 was measured with the sandwich enzyme immunoassay technique. The IL-8 kits were obtained from Diaclone (Besancon, France). The limit of detection was 62.5pg/mL.
RADIOIMMUNOASSAY OF DAINTAIN/AIF-1
In this assay, a polyclonal rabbit anti-porcine daintain/AIF-1 antiserum was used (15) together with 125 I-labeled peptide and highly purified daintain/ AIF-1 as standard, as previously described (12) . In brief, 100 µL antiserum diluted 1:1500, 100 µL labeled daintain/AIF-1, and 100 µL unknown or standard sample were mixed in tubes and incubated for 72-96hours at 4°C. The standard samples were made as serial dilutions of the peptide, from 100 to 0.2ng/mL. After incubation, 500 µL decanting suspension (Pharmacia, Uppsala, Sweden) with anti-rabbit im-munoglobulin sheep antiserum was added to precipitate the bound complexes. Following a 30-minute incubation at 4°C, the tubes were centrifuged for 10minutes at 1500g and the radioactivity of the precipitate containing antibody-bound material was counted in a gamma-scintillation spectrometer (LKBWallac, 1277 Gamma Master; Wallac Oy, Turku, Finland). The results are expressed as nanograms per milliliter daintain/AIF-1-like immunoreactivity. The intra-assay coefficient of variation averaged 0.8% and the interassay coefficient of variation was 2.4%-5.7% over the range of the standard curve (12) . The lowest level of detection was 0.39ng/mL in dialysates , supernatants from cell cultures, and serum.
Binding of recombinant human AIF-1 (16, 17) to the daintain/AIF-1 antibodies studied was demonstrated by Western blot, performed as previously described (18) . Human AIF-1 (0.2 µg) and porcine daintain/ AIF-1 (1 µg) were separated by SDS-PAGE (10%), followed by transblotting onto a nitrocellulose sheet (Immuno-Blot PVDF Membrane; Bio-Rad Laboratories, Hercules, California, USA). The protein blots were incubated overnight at 4°C with rabbit anti-porcine antiserum (diluted 1:100) in 1% dry milk, 0.2% Tween20, and 0.02% sodium azide/PBS. The blots were washed five times with PBS, then further incubated for 2hours at room temperature with goat antirabbit horseradish peroxidase (Bio-Rad) reacting with ECL Western Blot detection reagent (Amersham Pharmacia Biotech, Little Chalfont, Bucksh, UK), thus demonstrating daintain/AIF-1 protein by chemiluminescence. In the blots, the human peptide caused a distinct band at a position similar to porcine daintain/ AIF-1 (16.6kDA, data not shown).
STATISTICAL ANALYSIS
Data were analyzed using a one-way analysis of variance test followed by the Newman-Keuls test for two-mean comparison. A p value less than 0.05 was considered to be significant.
RESULTS
BACTERIOLOGICAL CULTURES
Bacterial growth was found in all but one of the dialysates. Staphylococcus epidermidis was found in 5episodes , S.aureus and E.coli in 2episodes eac h, and Streptococcus sanguinis, Strept. salivarius, Strept. acidominimus, Corynebacterium, and Klebsiella oxytoca in 1episode eac h. All patients were treated with netilmycin and vancomycin intraperitoneally and with a bolus dose of these drugs intravenously. If necessary, therapy was changed according to the susceptibility pattern.
DAINTAIN/AIF-1 PRODUCTION INDUCED DURING CAPD PERITONITIS
Daintain/AIF-1 levels were detected in all noninfected dialysates from the patients under investigation: median level 0.82 ng/mL, range 0.39 -2.13ng/mL (F igure1). On the first day of peritonitis, daintain/AIF-1 levels increased significantly and reached peak values in the first spent dialysate: 3.93ng/mL, range 1.41-8.77ng/mL ( p< 0.05 vs the noninfected state). During the following days, daintain/AIF-1 concentrations declined, and in samples from days 9to 12 there w as no difference compared to the noninfected state. Only in the serum sample from 1patient w as a significant increase observed. In the remaining samples, stationary or even slightly decreasing levels were found, indicating that the daintain/AIF-1 was locally produced and not transperitoneal leakage from the systemic circulation.
INCREASED DAINTAIN/AIF-1 PRODUCTION AT COMMENCEMENT OF CAPD
In all the investigated samples, the first effluent had a significantly higher (p< 0.05) daintain/AIF-1 release than samples obtained at 8weeks (F igure2). A rapid daintain/AIF-1 increase was observed for all live bacteria after only 2hours' stimulation of monocytes (p< 0.0001 vs initiation of stimulation, and p< 0.0009 vs nonstimulated cells). Escherichia coli induced its peak daintain/AIF-1 level (4.6ng/mL) after 4hours , thereafter leveling off and decreasing at 24hours . Staphylococcus aureus induced its peak value (5.5ng/mL) after 6hours; a continuous increase up to 24hours w as observed for S.epidermidis (4.3ng/mL) (F igure3).
Macrophages also showed daintain/AIF-1 response to bacterial stimulation. Escherichia coli and S.aureus reached significant levels after 2hours ( p< 0.0002, compared to initiation of stimulation and nonstimulated cells); significance was reached after 4hours for S.epidermidis (p< 0.004). Maximum levels were seen after 4hours for E.coli (3.4ng/mL), after 6hours for S.aureus (4.9ng/mL), and after 24hours for S.epidermidis (3.5ng/mL).
Interestingly, at all time points, stimulation with live bacteria induced a higher daintain/AIF-1 response in monocytes compared with macrophages. These differences reached significance at 2, 4, and 6hours for E.coli -stimulated cells (p< 0.0002), at 2, 4, and 24hours for S.aureus (p< 0.04), and at 2hours for S.epidermidis (p< 0.0001). Also, the constitutive production of daintain/AIF-1 increased and was higher after 6hours than at initiation.
In human peritoneal cells, consisting of a majority of macrophages (19), we found a significant increase in S.epidermidis -stimulated cells compared to nonstimulated cells and versus initiation of stimulation, 0hours ( p< 0.02).
HEAT INACTIVATION OF BACTERIA REDUCED DAINTAIN/AIF-1 RESPONSE IN MONOCYTES AND MACROPHAGES
In monocytes, after only 2hours of stimulation with heat inactivated E.coli or S.epidermidis , a significant increase in daintain/AIF-1 production was observed versus both initiation of stimulation (p< 0.0002) and nonstimulated cells (p< 0.0002 and 0.001 respectively). Peak levels were reached after 6hours , with maximum levels of 1.5ng/mL ( S.aureus ), 1.9ng/ mL (S.epidermidis ), and 2.3ng/mL ( E.coli ). This was also the first time point at which S.aureus was significantly higher than nonstimulated cells (p< 0.0002). In macrophages, E.coli induced a significant increase after 2hours ( p< 0.0003 vs initiation of stimulation and p< 0.0009 vs nonstimulated cells). Staphylococcus aureus and S.epidermidis reached a significant increase after 4hours ( p< 0.003 and p< 0.009 vs initiation; p< 0.02 and p< 0.05, respectively, vs nonstimulated cells). Peak levels were reached after 24hours ( E.coli 2.41ng/mL, S.aureus 2.16ng/mL, and S.epidermidis 2.0ng/mL), but at that time, constitutive production had also increased and there was no significant difference compared to nonstimulated cells. 
DISCUSSION
Three novel findings are presented in this paper. First, we show that CAPDpatients with peritonitis produce high levels of daintain/AIF-1, which are secreted into the peritoneal fluid during the infection. Second, commencement of dialysis induced daintain/ AIF-1 production, which decreased after 8weeks of therapy. Third, we demonstrate that both monocytes and macrophages in response to live S.epidermidis , S.aureus , or E.coli produced daintain/AIF-1, and that production was higher in monocytes than in macrophages. We also found that these cells stimulated with the same heat-inactivated bacteria produced less peptide.
The daintain/AIF-1 gene is located in the MHC classIII region (20) , together with genes encoding for other inflammatory proteins involved in immune and inflammatory responses, such as tumor necrosis factor-α and-β, complement, and heat shock protein (21) . A high degree of conserved amino acid sequence between the daintain/AIF-1 proteins in species as divergent as man and fish suggests that the peptide plays a functionally important role (22) . Daintain/AIF-1 is a Ca 2+ -binding peptide associated primarily with chronic inflammatory processes (8) . Expression of daintain/AIF-1 by infiltrating macrophages is a marker of disease activity that might be used to demonstrate "silent" lesions in the central nervous system and prolonged microglial cell activation (11) . However, microglia upregulation in the brain is not restricted to inflammation and tissue necrotizing processes. The microglia-responsefactor-1 (mrf-1), a homologue to AIF-1, was recently identified in microglia cells during apoptotic granular cell degeneration (23) . In chronically rejecting, macrophage-rich, rat cardiac allografts, AIF-1 is expressed early and persistently compared to isografts (7) . Consistent with the studies on rats, AIF-1 was expressed in human heart allografts, even in those with no obvious clinical or histological evidence of classic, diffuse, acute cellular rejection (8) . These conditions following organ transplantation demonstrate some similarities with CAPD in that there is persistence of a foreign body in a macrophage-rich milieu. Therefore, we investigated whether daintain/AIF-1 was prevalently expressed and if differences were observed over time in the peritoneal fluid of noninfected control patients on CAPD. Interestingly, we found the highest levels of the peptide in the first spent dialysate; during the 8-weekfollow-up, the levels were significantly lower or even undetectable. Thus, it can be speculated that daintain/ AIF-1 was produced as a response to the introduction of a foreign device.
Allograft inflammatory factor-1 appears to be expressed predominantly in cells from the myeloid lineage, such as monocytes/macrophages and neutrophils, and the transcript is constitutively expressed also in the THP-1 cell line (8) . Monocytes and macrophages, either dispersed in peritoneal dialysate or located under the mesothelium and perivascular areas, are of prime importance in the defense against bacterial peritonitis in CAPD patients. Hence, we chose a monocyte/macrophage cell line to study the influence of bacteria on daintain/AIF-1. The most commonly encountered micro-organism in CAPD peritonitis is S.epidermidis , followed by S.aureus and members of the family Enterobacteriaceae (e.g., E.coli ). Well-defined isolates of these bacteria were therefore used to stimulate monocytes and macrophages. We found a significant daintain/AIF-1 increase in both these cells in response to live E.coli , S.aureus , and S.epidermidis after 2hours; the stimulation reached its maximum after 4, 6, and 24hours , respectively. Compared to heat-inactivated bacteria, live bacteria induced a significantly higher release of daintain/AIF-1 from these cells. Our results are in concert with previous findings where LPS, being heatstable, did not produce AIF-1 (7). We can therefore hypothesize that heat-labile structures play an important role in the production and release of daintain/ AIF-1.
CAPD peritoneal cells have features of both immaturity and activation compared to control cells (24) . This is particularly true for peritoneal macrophages, which have been reported to be relatively immature cells (6, 25) , while characteristics such as increased respiratory burst activity and killing of Candida albicans blastophores suggest that they are functionally activated (26, 27) . We have previously shown that transmigration of monocytes into the peritoneal cavity during the noninfected steady state implies a selective upregulation of functional receptors, preferentially related to adhesion and antigen presentation (19) . It is also noteworthy that monocytes consistently had a higher daintain/AIF-1 production than macrophages. It may be speculated that cells from the peritoneal dialysis patients studied were immunologically modulated, with altered ability to exert a daintain/AIF-1 response.
On the transcriptional level, AIF-1 is an IFNγ-inducible molecule that is expressed within cells of the monocyte lineage and macrophages (7, 8) , dendritic cells from lymphatic organs (15) , microglial cells (10, 20) , and peripheral nerves (10) . When IFNγ was used to stimulate bone marrow-derived macrophages, a delayed increase in the AIF-1 transcript was demonstrated (7). Likewise, IL-1β showed an increase in the AIF-1 transcript (28). However, AIF-1 was not detected in extracts from the supernatant of IFNγ-stimulated cells (7) . Since both these cytokines are of importance in infections, it was natural to stimulate with these cytokines alone and in combination with bacteria. We were, however, not able to show daintain/ AIF-1 release by either IFNγ or IL-1β in supernatants from monocytes or macrophages, in spite of a 48-hour incubation time and a significant increase in IL-8 production ensuring adequate stimulation of the cells. The late increase in AIF-1 transcript suggests that its upregulation may be an indirect effect where intermediate steps could be involved. Although daintain/ AIF-1 seems to be cytokine inducible on the transcript level, the reasons for blunting conversion of the transcript to protein or release is not clear. It may be speculated that the increase in daintain/AIF-1 in the peritoneal effluent may stem from a local upregulation induced partly by IL-1β and/or IFNγ.
In conclusion, daintain/AIF-1 is upregulated during peritonitis in CAPDpatients . Monocytes and macrophages are likely to play an active part during the infection, since both these cells produced daintain/ AIF-1 in response to bacterial stimulation. Heatinactivated bacteria induced a slower and reduced daintain/AIF-1 response, indicating that heat-labile structures may be the most potent inducers of the peptide. Because of the early and significant daintain/ AIF-1 production in peritoneal fluid, it might, in doubtful cases, be helpful as an early marker of peritonitis.
